NOVAVAX INC's ticker is NVAX and the CUSIP is 670002401. A total of 378 filers reported holding NOVAVAX INC in Q1 2022. The put-call ratio across all filers is 1.88 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $6,225,705 | +0.3% | 859,904 | +2.9% | 0.02% | -11.1% |
| Q2 2023 | $6,209,251 | +192.7% | 835,700 | +173.0% | 0.02% | +260.0% |
| Q1 2023 | $2,121,273 | +5.8% | 306,100 | +57.0% | 0.01% | -16.7% |
| Q4 2022 | $2,004,600 | -37.2% | 195,000 | +11.2% | 0.01% | -40.0% |
| Q3 2022 | $3,192,000 | +27.1% | 175,400 | +259.2% | 0.01% | +42.9% |
| Q2 2022 | $2,511,000 | -63.5% | 48,828 | -47.7% | 0.01% | -68.2% |
| Q1 2022 | $6,872,000 | +44.7% | 93,300 | +181.0% | 0.02% | +46.7% |
| Q4 2021 | $4,750,000 | -75.3% | 33,200 | -64.2% | 0.02% | -78.3% |
| Q3 2021 | $19,239,000 | +9.2% | 92,800 | +11.8% | 0.07% | 0.0% |
| Q2 2021 | $17,622,000 | +4125.9% | 83,000 | +3508.7% | 0.07% | +3350.0% |
| Q1 2021 | $417,000 | -6.5% | 2,300 | -42.5% | 0.00% | 0.0% |
| Q4 2020 | $446,000 | -78.7% | 4,000 | -79.3% | 0.00% | -83.3% |
| Q3 2020 | $2,091,000 | +563.8% | 19,300 | +410.7% | 0.01% | +500.0% |
| Q2 2020 | $315,000 | – | 3,779 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Foresite Capital Management I, LLC | 66,810 | $13,850,000 | 10.84% |
| Parametrica Management Ltd | 60,296 | $12,484,000 | 9.33% |
| RA Capital Management | 2,097,794 | $434,894,000 | 6.03% |
| Foresite Capital Management II, LLC | 67,373 | $13,967,000 | 4.96% |
| Samsara BioCapital, LLC | 82,600 | $17,124,000 | 2.69% |
| Rock Springs Capital Management LP | 455,000 | $94,326,000 | 1.98% |
| Tri Locum Partners LP | 19,300 | $4,001,000 | 1.59% |
| SECTORAL ASSET MANAGEMENT INC | 89,450 | $18,544,000 | 1.54% |
| Foresite Capital Management III, LLC | 5,000 | $1,037,000 | 1.44% |
| TSP Capital Management Group, LLC | 18,525 | $3,840,000 | 1.31% |